Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Effect of alpha-lipoic acid and myoinositol on endometrial inflammasome from recurrent pregnancy loss women.

Di Nicuolo F, D'Ippolito S, Castellani R, Rossi ED, Masciullo V, Specchia M, Mariani M, Pontecorvi A, Scambia G, Di Simone N.

Am J Reprod Immunol. 2019 Sep;82(3):e13153. doi: 10.1111/aji.13153. Epub 2019 Jun 19.

PMID:
31148259
2.

Correction to: Recurrent pregnancy loss is associated to leaky gut: a novel pathogenic model of endometrium inflammation?

Tersigni C, D'Ippolito S, Di Nicuolo F, Marana R, Valenza V, Masciullo V, Scaldaferri F, Malatacca F, de Waure C, Gasbarrini A, Scambia G, Di Simone N.

J Transl Med. 2019 Mar 15;17(1):83. doi: 10.1186/s12967-019-1823-5.

3.

Recurrent pregnancy loss is associated to leaky gut: a novel pathogenic model of endometrium inflammation?

Tersigni C, D'Ippolito S, Di Nicuolo F, Marana R, Valenza V, Masciullo V, Scaldaferri F, Malatacca F, de Waure C, Gasbarrini A, Scambia G, Di Simone N.

J Transl Med. 2018 Apr 17;16(1):102. doi: 10.1186/s12967-018-1482-y. Erratum in: J Transl Med. 2019 Mar 15;17(1):83.

4.

The cl2/dro1/ccdc80 null mice develop thyroid and ovarian neoplasias.

Leone V, Ferraro A, Schepis F, Federico A, Sepe R, Arra C, Langella C, Palma G, De Lorenzo C, Troncone G, Masciullo V, Scambia G, Fusco A, Pallante P.

Cancer Lett. 2015 Feb 28;357(2):535-41. doi: 10.1016/j.canlet.2014.12.010. Epub 2014 Dec 9.

PMID:
25497869
5.

Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study.

Ferrandina G, Corrado G, Mascilini F, Malaguti P, Samaritani R, Distefano M, Masciullo V, Di Legge A, Savarese A, Scambia G.

BMC Cancer. 2014 Dec 13;14:947. doi: 10.1186/1471-2407-14-947.

6.

Emerging drugs for endometrial cancer.

Amadio G, Masciullo V, Ferrandina MG, Scambia G.

Expert Opin Emerg Drugs. 2014 Dec;19(4):497-509. doi: 10.1517/14728214.2014.971752. Epub 2014 Oct 21. Review.

PMID:
25330855
7.

Hysteroscopic treatment of symptomatic cesarean-induced isthmocele: a prospective study.

Raimondo G, Grifone G, Raimondo D, Seracchioli R, Scambia G, Masciullo V.

J Minim Invasive Gynecol. 2015 Feb;22(2):297-301. doi: 10.1016/j.jmig.2014.09.011. Epub 2014 Oct 5.

PMID:
25285773
8.

Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence.

Mascilini F, Amadio G, Di Stefano MG, Ludovisi M, Di Legge A, Conte C, De Vincenzo R, Ricci C, Masciullo V, Salutari V, Scambia G, Ferrandina G.

Onco Targets Ther. 2014 Jul 12;7:1273-84. doi: 10.2147/OTT.S51550. eCollection 2014. Review.

9.

An update on the pharmacotherapy for endometrial cancer.

Amadio G, Masciullo V, Stefano L, Scambia G.

Expert Opin Pharmacother. 2013 Dec;14(18):2501-9. doi: 10.1517/14656566.2013.849241. Epub 2013 Oct 21. Review.

PMID:
24138224
10.

Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients.

Lorusso D, Scambia G, Amadio G, di Legge A, Pietragalla A, De Vincenzo R, Masciullo V, Di Stefano M, Mangili G, Citterio G, Mantori M, Lambiase A, Bordignon C.

Br J Cancer. 2012 Jun 26;107(1):37-42. doi: 10.1038/bjc.2012.233. Epub 2012 May 29.

11.

Phase II study on weekly bolus topotecan in advanced or recurrent cervical cancer.

Lorusso D, Mainenti S, Pietragalla A, Fusco E, Malaguti P, Masciullo V, Scambia G.

Oncology. 2011;80(5-6):390-4. doi: 10.1159/000330537. Epub 2011 Aug 5.

PMID:
21829040
12.

Lethal Clostridium difficile Colitis Associated with Paclitaxel and Carboplatin Chemotherapy in Ovarian Carcinoma: Case Report and Review of the Literature.

Masciullo V, Mainenti S, Lorusso D, Margariti PA, Scambia G.

Obstet Gynecol Int. 2010;2010. pii: 749789. doi: 10.1155/2010/749789. Epub 2010 Jul 18.

13.

Controversies in the management of endometrial cancer.

Masciullo V, Amadio G, Lo Russo D, Raimondo I, Giordano A, Scambia G.

Obstet Gynecol Int. 2010;2010:638165. doi: 10.1155/2010/638165. Epub 2010 Jun 16.

14.

Brostallicin (PNU-166196), a new minor groove DNA binder: preclinical and clinical activity.

Lorusso D, Mainenti S, Pietragalla A, Ferrandina G, Foco G, Masciullo V, Scambia G.

Expert Opin Investig Drugs. 2009 Dec;18(12):1939-46. doi: 10.1517/13543780903401284.

PMID:
19938904
15.

Review role of topotecan in gynaecological cancers: current indications and perspectives.

Lorusso D, Pietragalla A, Mainenti S, Masciullo V, Di Vagno G, Scambia G.

Crit Rev Oncol Hematol. 2010 Jun;74(3):163-74. doi: 10.1016/j.critrevonc.2009.08.001. Epub 2009 Sep 18. Review.

PMID:
19766512
16.

Conservative surgical management of stage IA endometrial carcinoma for fertility preservation.

Mazzon I, Corrado G, Masciullo V, Morricone D, Ferrandina G, Scambia G.

Fertil Steril. 2010 Mar 1;93(4):1286-9. doi: 10.1016/j.fertnstert.2008.12.009. Epub 2009 Aug 22.

PMID:
19700153
17.

Cyclin E correlates with manganese superoxide dismutase expression and predicts survival in early breast cancer patients receiving adjuvant epirubicin-based chemotherapy.

Sgambato A, Camerini A, Collecchi P, Graziani C, Bevilacqua G, Capodanno A, Migaldi M, Masciullo V, Scambia G, Rossi G, Cittadini A, Amoroso D.

Cancer Sci. 2009 Jun;100(6):1026-33. doi: 10.1111/j.1349-7006.2009.01141.x. Epub 2009 Mar 31.

18.

The retinoblastoma family member pRb2/p130 is an independent predictor of survival in human soft tissue sarcomas.

Masciullo V, Berardengo E, Boglione A, Sgambato A, Bernardi A, Forni M, Linari A, Cito L, Scambia G, Comandone A, Giordano A.

Clin Cancer Res. 2008 Aug 1;14(15):4775-9. doi: 10.1158/1078-0432.CCR-07-4055.

19.

Importance of a specialized pathologist for the examination of frozen sections of adnexal masses.

Fanfani F, Zannoni GF, Fagotti A, Gagliardi ML, Masciullo V, Testa AC, Scambia G.

Int J Gynecol Cancer. 2007 Sep-Oct;17(5):1034-9. Epub 2007 Mar 28.

PMID:
17388916
20.

Low frequency of hCDC4 mutations in human primary ovarian cancer.

Sgambato A, Cittadini A, Masciullo V, Di Salvatore M, Graziani C, Rettino A, Valdivieso P, Scambia G, Bianchino G, Zupa A, Improta G, Cifarelli RA.

Gynecol Oncol. 2007 May;105(2):553-5. Epub 2007 Feb 23. No abstract available.

PMID:
17320938
21.

UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas.

Berlingieri MT, Pallante P, Guida M, Nappi C, Masciullo V, Scambia G, Ferraro A, Leone V, Sboner A, Barbareschi M, Ferro A, Troncone G, Fusco A.

Oncogene. 2007 Mar 29;26(14):2136-40. Epub 2006 Oct 2.

PMID:
17016443
22.

RB family members as predictive and prognostic factors in human cancer.

Scambia G, Lovergine S, Masciullo V.

Oncogene. 2006 Aug 28;25(38):5302-8.

PMID:
16936751
23.

p27kip1 overexpression promotes paclitaxel-induced apoptosis in pRb-defective SaOs-2 cells.

Gabellini C, Pucci B, Valdivieso P, D'Andrilli G, Tafani M, De Luca A, Masciullo V.

J Cell Biochem. 2006 Aug 15;98(6):1645-52.

PMID:
16598766
24.

Endometrioid adenocarcinoma with squamous differentiation arising from ureteral endometriosis in a patient with no history of gonadal endometriosis.

Salerno MG, Masciullo V, Naldini A, Zannoni GF, Vellone V, Scambia G.

Gynecol Oncol. 2005 Dec;99(3):749-52. Epub 2005 Oct 13.

PMID:
16226301
25.

pRb2/p130 decreases sensitivity to apoptosis induced by camptothecin and doxorubicin but not by taxol.

Tonini T, Gabellini C, Bagella L, D'Andrilli G, Masciullo V, Romano G, Scambia G, Zupi G, Giordano A.

Clin Cancer Res. 2004 Dec 1;10(23):8085-93.

26.

Frequent loss of pRb2/p130 in human ovarian carcinoma.

D'Andrilli G, Masciullo V, Bagella L, Tonini T, Minimo C, Zannoni GF, Giuntoli RL 2nd, Carlson JA Jr, Soprano DR, Soprano KJ, Scambia G, Giordano A.

Clin Cancer Res. 2004 May 1;10(9):3098-103.

27.

The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity.

Cortellino S, Turner D, Masciullo V, Schepis F, Albino D, Daniel R, Skalka AM, Meropol NJ, Alberti C, Larue L, Bellacosa A.

Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15071-6. Epub 2003 Nov 12.

28.

Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas.

Masciullo V, Susini T, Zamparelli A, Bovicelli A, Minimo C, Massi D, Taddei G, Maggiano N, De Iaco P, Ceccaroni M, Bovicelli L, Amunni G, Mancuso S, Scambia G, Giordano A.

Clin Cancer Res. 2003 Nov 1;9(14):5332-8.

29.

HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas.

Masciullo V, Baldassarre G, Pentimalli F, Berlingieri MT, Boccia A, Chiappetta G, Palazzo J, Manfioletti G, Giancotti V, Viglietto G, Scambia G, Fusco A.

Carcinogenesis. 2003 Jul;24(7):1191-8. Epub 2003 May 9.

PMID:
12807722
30.

Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27.

Cesari R, Martin ES, Calin GA, Pentimalli F, Bichi R, McAdams H, Trapasso F, Drusco A, Shimizu M, Masciullo V, D'Andrilli G, Scambia G, Picchio MC, Alder H, Godwin AK, Croce CM.

Proc Natl Acad Sci U S A. 2003 May 13;100(10):5956-61. Epub 2003 Apr 28.

31.

Loss of pRb2/p130 expression is associated with unfavorable clinical outcome in lung cancer.

Caputi M, Groeger AM, Esposito V, De Luca A, Masciullo V, Mancini A, Baldi F, Wolner E, Giordano A.

Clin Cancer Res. 2002 Dec;8(12):3850-6. Erratum in: Clin Cancer Res. 2004 Jul;9(7):2876.

32.

pRb2/p130 promotes radiation-induced cell death in the glioblastoma cell line HJC12 by p73 upregulation and Bcl-2 downregulation.

Pucci B, Claudio PP, Masciullo V, Bellincampi L, Terrinoni A, Khalili K, Melino G, Giordano A.

Oncogene. 2002 Aug 29;21(38):5897-905.

33.

Cell cycle genes as targets of retinoid induced ovarian tumor cell growth suppression.

Zhang D, Vuocolo S, Masciullo V, Sava T, Giordano A, Soprano DR, Soprano KJ.

Oncogene. 2001 Nov 29;20(55):7935-44.

34.

Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.

Susini T, Massi D, Paglierani M, Masciullo V, Scambia G, Giordano A, Amunni G, Massi G, Taddei GL.

Hum Pathol. 2001 Apr;32(4):360-7.

PMID:
11331952
35.

Expression of cell-cycle-associated proteins pRB2/p130 and p27kip in vulvar squamous cell carcinomas.

Zamparelli A, Masciullo V, Bovicelli A, Santini D, Ferrandina G, Minimo C, Terzano P, Costa S, Cinti C, Ceccarelli C, Mancuso S, Scambia G, Bovicelli L, Giordano A.

Hum Pathol. 2001 Jan;32(1):4-9.

PMID:
11172288
36.

p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis.

Masciullo V, Ferrandina G, Pucci B, Fanfani F, Lovergine S, Palazzo J, Zannoni G, Mancuso S, Scambia G, Giordano A.

Clin Cancer Res. 2000 Dec;6(12):4816-22.

37.

The Rb family of cell cycle regulatory factors: clinical implications.

Masciullo V, Khalili K, Giordano A.

Int J Oncol. 2000 Nov;17(5):897-902. Review.

PMID:
11029489
38.

High cyclin-dependent kinase inhibitors in Bcl-2 and Bcl-xL-expressing CD34+-proliferating haematopoietic progenitors.

Marone M, Pierelli L, Mozzetti S, Masciullo V, Bonanno G, Morosetti R, Rutella S, Battaglia A, Rumi C, Mancuso S, Leone G, Giordano A, Scambia G.

Br J Haematol. 2000 Sep;110(3):654-62.

PMID:
10997978
39.

The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability.

Riccio A, Aaltonen LA, Godwin AK, Loukola A, Percesepe A, Salovaara R, Masciullo V, Genuardi M, Paravatou-Petsotas M, Bassi DE, Ruggeri BA, Klein-Szanto AJ, Testa JR, Neri G, Bellacosa A.

Nat Genet. 1999 Nov;23(3):266-8. No abstract available.

PMID:
10545939
40.

Paclitaxel induces apoptosis in Saos-2 cells with CD95L upregulation and Bcl-2 phosphorylation.

Pucci B, Bellincampi L, Tafani M, Masciullo V, Melino G, Giordano A.

Exp Cell Res. 1999 Oct 10;252(1):134-43.

PMID:
10502406
41.

[A zinc sulfate and usnic acid preparation used as post-surgical adjuvant therapy in genital lesions by Human Papillomavirus].

Scirpa P, Scambia G, Masciullo V, Battaglia F, Foti E, Lopez R, Villa P, Malecore M, Mancuso S.

Minerva Ginecol. 1999 Jun;51(6):255-60. Italian.

PMID:
10479878
42.

Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer.

Masciullo V, Sgambato A, Pacilio C, Pucci B, Ferrandina G, Palazzo J, Carbone A, Cittadini A, Mancuso S, Scambia G, Giordano A.

Cancer Res. 1999 Aug 1;59(15):3790-4.

43.

[Therapy of bacterial vaginosis. Prospective clinical study ot the efficacy and tolerability of quaternary ammonium salts vs. clindamycin].

Battaglia F, Scambia G, De Vincenzo R, Distefano M, Lopez R, Masciullo V, Foti E, Scirpa P, Margariti PA, Panici PB, Mancuso S.

Minerva Ginecol. 1998 Mar;50(3):109-19. Review. Italian.

PMID:
9595926
44.

Analysis of cyclin E and CDK2 in ovarian cancer: gene amplification and RNA overexpression.

Marone M, Scambia G, Giannitelli C, Ferrandina G, Masciullo V, Bellacosa A, Benedetti-Panici P, Mancuso S.

Int J Cancer. 1998 Jan 5;75(1):34-9.

45.

Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomas.

Masciullo V, Scambia G, Marone M, Giannitelli C, Ferrandina G, Bellacosa A, Benedetti Panici P, Mancuso S.

Int J Cancer. 1997 Aug 22;74(4):390-5.

46.

Prognostic significance of ras/p21 alterations in human ovarian cancer.

Scambia G, Masciullo V, Benedetti Panici P, Marone M, Ferrandina G, Todaro N, Bellacosa A, Jain SK, Neri G, Piffanelli A, Mancuso S.

Br J Cancer. 1997;75(10):1547-53.

47.

Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.

Bellacosa A, de Feo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA, Wan M, Dubeau L, Scambia G, Masciullo V, Ferrandina G, Benedetti Panici P, Mancuso S, Neri G, Testa JR.

Int J Cancer. 1995 Aug 22;64(4):280-5.

PMID:
7657393
48.

Interleukin-6 serum levels in patients with gynecological tumors.

Scambia G, Testa U, Panici PB, Martucci R, Foti E, Petrini M, Amoroso M, Masciullo V, Peschle C, Mancuso S.

Int J Cancer. 1994 May 1;57(3):318-23.

PMID:
8168990
49.

Quercetin enhances transforming growth factor beta 1 secretion by human ovarian cancer cells.

Scambia G, Panici PB, Ranelletti FO, Ferrandina G, De Vincenzo R, Piantelli M, Masciullo V, Bonanno G, Isola G, Mancuso S.

Int J Cancer. 1994 Apr 15;57(2):211-5.

PMID:
8157359

Supplemental Content

Loading ...
Support Center